Дифференцировка клеток обратима: соматические научились превращать в плюрипотентные стволовые Medline.ru - медико-биологический информационный портал Медлайн.ру

1. Никольский Н.Н., Габай И.А., Сомова Н.В. Эмбриональные стволовые клетки человека. Проблемы и перспективы. Обзор. Цитология. 2007; 49: 259-236

2. Adhikary S., Eilers M. Transcriptional regulation and transformation by Myc proteins. Review. Nature Rev. Molecular Cell Biology. 2005; 6: 635-645

3. Allegrucci C., Young L.E. Differences between human embryonic stem cell lines. Human Reproduct. 2007; 13: 103-120

4. Aoi T., Yae K., Nakagawa M., Ichisaka T., Okita K., Takahashi K., Chiba T., Yamanaka S. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science Express 2008; published on line 14 February

5. Baker M. Mouse skin cells made pluripotent by genetic modification can give rise to all types of tissue. Nature Reports Stem Cells. Published online: 7 June 2007

6. Bang A.G., Carpenter M.K. Reconstructing pluripotency. Science. 2008; 380: 58-59

7. Bibikova M., Laurent L.C., Ren B. et al. Unraveling Epigenetic Regulation in Embryonic Stem Cells. Review. Cell Stem Cells. 2008; 2: 123-134

8. Blelloch, R., Venere, M., Yen, J., Ramalho-Santos, M. Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell. 2007: 1; 245–247

9. Brambrink T., Foreman R., Welstead G. et al. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell. Stem Cells. 2008; 2: 151-159

10. Buszczak M., Spradling A. Searching Chromatin for Stem Cell Identity. Cell. 2006; 125: 233-236

11. Cowan, C.A., Atienza, J., Melton, D.A., Eggan, K. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science. 2005: 309; 1369–1373

12. Cyranoski D. Race to mimic human embryonic stem cells. Nature. 2007; 450: 462-463

13. Cyranoski D. Verdict: Hwang’s human stem cells were all fakes. Nature. 2006; 439: 122-123

14. Fourse S.D., Shen Y. et al. Promoter CpG Methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell Stem Cell. 2008; 2: 160–169

15. Gottweis H., Minger S. iPS and the politics of promises. Nature Biotechnology. 2008; 26: 271-272

16. Guhr A., Kurtz A., Friedgen K., Oser P.L. Current state of human embryonic stem cell research: an overview of cell lines and their use in experimental work. Stem Cells. 2006; 24: 2187-2191

17. Hanna J., Markoulaki S., Schorderet P. et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell. 2008; 133: 250-264

18. Hanna J., Wernig M., Markoulaki S. et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007; 318 : 1920-23

19. Hattori N., Nishino K. et al. Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. J. Biol. Chem. 2004; 279: 17063-17069

20. Hawley R.G., Sobieski D.A. Somatic stem cell plasticity: To be or not to be... Stem Cells. 2002; 20: 195-197

21. Hochedlinger, K., Jaenisch, R. Nuclear transplantation, embryonic stem cells, and the potential for cell therapy. Review. New Engl. J. Med. 2003; 349: 275–286

22. Hochedlinger, K., and Jaenisch, R. Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature. 2002; 415: 1035–1038

23. Holden C., Vogel G. A seismic shift for stem cell research. Science. 2008; 319: 560-550

24. Itskovitz-Eldor J., Schuldiner M., Karsenti et al. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol. Med. 2000; 6: 88–95

25. Ivanova N., Dobrin R., Lu R. et al. Dissecting self-reneval in stem cells with RNA intereference. Review. Nature. 2006; 442; 533-538

26. Jaenisch R., Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Review. Cell. 2008; 132: 567–582

27. Jones P., Baylin S. The epigenomics of cancer. Review. Cell. 2007; 128: 683-692

28. Kim J., Chu J., Shen X., Wang J., Orkin S.H. An extended transcriptional network for pluripotency of embryonic stem cells. Cell. 2008; 132: 1049–1061

29. Knoepfler P.S. Why Myc? An Unexpected ingredient in the stem cell cocktail. Minireview. Cell Stem Cell. 2008; 2: 18-21

30. Levitzky M., Yamanaka S., Reprogramming somatic cells toward pluripotency by defined factors. Review. Current Opinion Biotechnology. 2007; 18: 467-473

31. Lowry W.E., L. Richter L., Yachechko R. et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. PNAS. 2008; 105: 2883–2888

32. Maherali, N., Sridharan, R. Xie, W. et al. Global epigenetic remodeling in directly reprogrammed fibroblasts. Cell Stem Cell. 2007; 1: 55–70

33. Masaki, H., Ishikawa T. et al. Heterogeneity of pluripotent marker gene expression in colonies generated in human iPS cell induction culture, Stem Cell Res. 2008; doi:10.1016/j.scr.

34. Meissner, A., Wernig, M., Jaenisch, R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol. 2007; 25: 1177–1181

35. Meshorer E., Mistoli T. Chromatin in pluripotent embryonic stem cells and differentiation. Review. Nature Rev. Mol. Cell Biol. 2006; 7: 540-546

36. Mikkola M., Olsson C., Palgi J. et al. Distinct differentiation characteristics of individual human embryonic stem cell lines. BMC Developmental Biology. 2006; 6: 40

37. Morshead CM, Benveniste P, Iscove NN et al. Hematopoietic competence is a rare property of neural stem cells that may depend on genetic and epigenetic alterations. Nature Medicine. 2002; 8: 268-273

38. Nakagawa, M., Koyanagi, M., Tanabe, K. et al. Generation of induced pluripotent stem cells without Myc from mouse and human. Nature Biotechnology. 2008; 26: 101-106

39. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448: 313–317

40. Panneteier M., Feil R. Epigenetic stability of embryonic stem cells and developmental potential. Review. Trends Biotechnol. 2007; 25: 556-562

41.Park I.H., Zhao R., West J. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008; 451: 141-147

42. Pera M.F., Hasegawa K. Simpler and suffer cell reprogramming. Nature Biotechnology. 2008; 26: 59-60

43. Phinney D.G., Prockop D.J. Mesenchymal stem/multi-potent stromal cells (MSCs): the state of transdifferentiation and modes of tissue repair - current views. Stem Cells. 2007; 25: 2896- 2902

44. Preston S.L., Alison M.R., et al. The new stem cell biology: something for everyone. Review. J Clin Pathol: Mol Pathol. 2003; 56: 86–96

45. Rossat H. Stem cells: The magic brew. Nature 2007; 448: 260-262

46. Ruau D., Ensenat-Waser R., Timo C. Dinger TC. et al. Pluripotency associated genes are rcactivated by chromatin modifying agents in neurosphere cells. Stem Cells Express. 2008; first published online January 17

47. Shaun D. Fouse,1 Yin Shen,1 уet al. Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell Stem Cell. 2008; 2: 160–169

48. Schmittwolf C, Kirchhof N, Jauch A et al. In vivo haematopoietic activity is induced in neurosphere cells by chromatin-modifying agents. EMBO J. 2005; 24: 554-566.

49. Spivakov M., Fisher A.G. Epigenetic signatures of stem cells. Review. Nature Rev. Genetics. 2007; 8: 263-271

50. Stadtfeld M., Nimet Maherali N., David T. Breault D.T., Hochedlinger K. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell. 2008; 2: 230–240

51.Sumi T., Tsuneyoshi N., Nakatsuji N. et al. Apoptosis and differentiation of human embryonic stem cells induced by sustained activation of c-Myc. Oncogene. 2007; 26: 5564–5576

52. Surani M.A., Hayashi K., Hajkova P. Genetic and epigenetic regulators of pluripotency. Review. Cell. 2007; 128: 747–762

53. Tada, M., Takahama, Y., Abe, K., Nakatsuji, N. and Tada, T. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Current Biol. 2001; 11: 1553–1558

54. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126: 663–76

55. Takahashi K., Yamanaka S., Tanabe K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131 : 861-72

56. Taranger C.K., Noer A., Sorensen A.L. et al. Induction of dedifferentiation, genome wide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol. Biol. Cell. 2005; 16: 5719-5735

57. Tsuji-Takayama K., Inoue T. et al. Demethylating agent, 5-azacytidine, reverses differentiation of embryonic stem cells. Bioch. Bioph. Res. Com. 2004; 323: 86-90

58. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282: 1145–1147

59. Ullmann U., In’t Veld P., et al. Epithelial–mesenchymal transition process in human embryonic stem cells cultured in feeder-free conditions. Mol. Human Reproduction. 2007:13: 21–32

60. Vogel G., Holden C. Field Leaps Forward With New Stem Cell Advances. Science. 2007; 318: 1224-1225

61. Wagers A.J., Weissman I.L. Plasticity of adult stem cells. Review. Cell. 2004; 116: 639–648

62. Wang Y. Armstrong S.A. Cancer: Inappropriate Expression of Stem Cell Programs? Cell Stem Cell. 2008; 2: 297-299

63. Wernig M., Meissner, A., Foreman, R. et al. In vitro reprogrammed fibroblasts have a similar developmental potential as ES cells and an ES cell-like epigenetic state. Nature. 2007; 448: 318-325

64. Wernig M., Alexander Meissner A., Cassady J.P., Jaenisch R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell. Stem Cells. 2008; 2: 10-13

65. Wernig M., Zhao J-P., Pruszak J. et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. PNAS. 2008; 105: 5856-5861

66. Wilmut I. The first direct reprogramming of adult human fibroblasts. Cell Stem Cells. 2007; 1: 593-594

67. Wobus A.M., Boheler K.R. Embryonic stem cells: prospects for developmental biology and cell Therapy. Review. Physiol. Rev. 2005; 85: 635-678

68. Wong D.J., Liu H. et al. Module map of stem cell genes guides creation of epithelial cancer stem cells, Cell Stem Cell. 2008; 2: 333–344

69. Wu L.C., Sun C.W., Ryan T.M., et al. Correction of sickle cell disease by homologous recombination in embryonic stem cells. Blood. 2006; 108: 1183-1188

70. Zaehres H., Schuler H.R. Induction of pluripotency: from mouse to human. Cell. 2007; 131: 864-865

71. Yamanaka, S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Review. Cell Stem Cell. 2007; 1: 39–49.

72. Yang, X., Smith, S.L., et al. Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning. Nat. Genet. 2007; 39: 295–302.

73. Yu J., Vodyanik M.A., Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007; 318 : 1917-1920